In vitro growth inhibition of murine leukemia cells by antibody specific for the major envelope glycoprotein (gp71) of friend leukemia virus

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Journal of Cellular Physiology

• Publication date

  1983-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jcp.1041170213PMID 6630299
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis and expression of surface antigens during the cell cycle.

  2008cited by this paper
• Biological effects of antibodies to lymphocyte surface receptors

  2005cited by this paper
• Independence of H-2 and viral antigens on the cell surface and absence of H-2 antigens on murine leukemia virus and mouse mammary tumor virus particles

  2004cited by this paper
• Sorting of B lymphoblasts based upon cell diameter provides cell populations enriched in different stages of cell cycle.

  1983cited by this paper
• Immunotherapy of murine leukemia. IX. The requirement for the Fc portion of antibody for successful passive serum therapy of Friend leukemia virus-induced disease.

  1983cited by this paper
• Use of monoclonal anti-gp70 antibodies to mimic the effects of the Rfv-3 gene in mice with Friend virus-induced leukemia.

  1983cited by this paper
• Immunotherapy of murine leukemia. VIII. Efficacy of passive serum therapy of Friend leukemia virus-induced disease in immunocompromised mice.

  1983cited by this paper
• Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro.

  1982cited by this paper
• Initial Characterization of a Spontaneous Interferon Secreted During Growth and Differentiation of Friend Erythroleukemia Cells

  1982cited by this paper
• Antibody-dependent cytolysis of the human leukemia cell line K-562 in the absence of effector cells or complement.

  1982cited by this paper
• Crystal structure of a microbial ribonuclease, RNase St

  1982cited by this paper
• Immunotherapy of a murine leukemia virus-infected, chemically induced murine sarcoma with antiviral antibodies.

  1982cited by this paper
• Microinjection of monoclonal antibody to protein p53 inhibits serum-induced DNA synthesis in 3T3 cells.

  1982cited by this paper
• Immunotherapy of murine leukemia VI. Development of immunologic memory in mice protected against Friend leukemia virus-induced disease by passive serum therapy.

  1982cited by this paper
• Murine cell surface transferrin receptor: Studies with an anti‐receptor monoclonal antibody

  1982cited by this paper
• Immunotherapy of murine leukemia. VII. Prevention of friend leukemia virus‐induced immunosuppression by passive serum therapy

  1982cited by this paper
• Inhibition of antigen-induced T-cell proliferation by antibodies to endogenous AKR-MuLV.

  1981cited by this paper
• Subcellular localization of the env-related glycoproteins in Friend erythroleukemia cells

  1981cited by this paper
• In vivo antigenic modification of tumor cells. I. Introduction of murine leukemia virus antigens on non-virus-producing murine sarcomas.

  1981cited by this paper
• Elevated urine estrogen and pregnanediol levels in daughters of breast cancer patients.

  1981cited by this paper
• Immunologic control of the ascites form of murine adenocarcinoma 755. IV. Characterization of the protective antibody in hyperimmune serum.

  1981cited by this paper
• Retrovirus gene expression during the cell cycle. I. Virus production, synthesis, and expression of viral proteins in Rauscher murine leukemia virus-infected mouse cells

  1981cited by this paper
• Morphologic changes in the murine leukemia L5178Y cells treated with antibodies in the absence of complement activity.

  1981cited by this paper
• Immunotherapy of murine leukemia. V. Protection against Friend leukemia virus-induced immune complex glomerulonephritis by passive serum therapy.

  1981cited by this paper
• Adoptive transfer of antiviral resistance by lymphoid cells from mice protected against Friend leukemia virus-induced disease by passive serum therapy.

  1981cited by this paper
• The effect of anti-immunoglobulin antibodies on the in vitro proliferation and differentiation of normal and neoplastic murineB cells.

  1980cited by this paper
• Murine leukaemogenesis: monoclonal antibodies to T-cell determinants arrest T-lymphoma cell proliferation

  1980cited by this paper
• Absence of macrophage involvement in the passive serum therapy of Friend leukemia virus-induced disease.

  1980cited by this paper
• Inhibition of calcium and glucose uptake by murine leukemia L5178Y cells treated with antiserum

  1980cited by this paper
• Subcompartments of the G1 phase of cell cycle detected by flow cytometry.

  1980cited by this paper
• Effect of serum from mice with dormant Friend leukemia viral infections on synthesis and modulation of erythroleukemia cell surface gp70.

  1980cited by this paper
• Antigenic modulation as a mechanism for tumor escape from immune destruction: identification of modulation-positive and modulation-negative mouse lymphomas with xenoantisera to murine leukemia virus gp70.

  1980cited by this paper
• Intracellular neutralization of SV40 tumor antigens following microinjection of specific antibody.

  1980cited by this paper
• Immunotherapy of murine leukemia. II. Effect of passive serum therapy on Friend murine leukemia virus-induced hematologic and coagulation parameters.

  1980cited by this paper
• Persistence of passively transferred goat F(ab')2 antibody fragments in the circulation of rodents.

  1980cited by this paper
• Membrane and cytoplasmic changes in virus-infected cells induced by interactions of antiviral antibody with surface viral antigen.

  1980cited by this paper
• Alterations in expression of measles virus polypeptides by antibody: molecular events in antibody-induced antigenic modulation.

  1980cited by this paper
• A Putative Role of Endogenous C-Type Virus in the Immune System

  1979cited by this paper
• Selective cell surface expression of thymus leukemia antigen during S phase of the cell cycle.

  1979cited by this paper
• Inhibition of growth of ASL-1w murine leukemia cells by anti-thymus leukemia antigen (TL) serum in the absence of complement.

  1979cited by this paper
• Studies on the Fc gamma receptor of the murine macrophage-like cell line P388D1. I. The binding of homologous and heterologous immunoglobulin G1.

  1979cited by this paper
• Fcγ Receptor of the Murine Macrophage-Like Cell Line P388D1 I. The Binding of Homologous and Heterologous Immunoglobulin G

  1979cited by this paper
• Complement and cell-mediated lysis of haptenated erythrocytes sensitized with oligomers of rabbit IgG antibody.

  1979cited by this paper
• Studies on the Fcγ Receptor of the Murine Macrophage-Like Cell Line P388D1

  1979cited by this paper
• Antibody and complement modulation of tumor cell growth in vitro and in vivo.

  1978cited by this paper
• Immunologic control of the ascites form of murine adenocarcinoma 755. II. Tumor immunity associated with a Friend--Moloney--Ra,scher-type virus.

  1978cited by this paper
• Immunologic control of the ascites of murine adenocarcinoma 755. I. Protection with syngeneic immune serum or lymphoid cells.

  1978cited by this paper
• Immunotherapy of murine leukemia. I. protection against friend leukemia virus‐induced disease by passive serum therapy

  1978cited by this paper
• Anti-Friend virus antibody-induced resistance of Friend virus-infected spleen cells to lysis mediated by anti-H-2 antisera.

  1978cited by this paper
• Evidence for Fc surface receptors on friend murine erythroleukemic cells

  1978cited by this paper
• Participation of histocompatibility antigens in capping of molecularly independent cell surface components by their specific antibodies.

  1978cited by this paper
• Normal chicken cells (chf-) express a surface antigen which cross-reacts with determinants of the major envelope glycoprotein (gp85) of avian myeloblastosis virus.

  1978cited by this paper
• Properties of mouse leukemia viruses. XIV. Prevention of spontaneous AKR leukemia by treatment with group-specific antibody against the major virus gp71 glycoprotein.

  1977cited by this paper
• Specificity and distribution of the determinants of the major glycoprotein (gp71) of murine oncornaviruses as detected by an in vitro cytotoxicity assay.

  1977cited by this paper
• Antigenic modulation of Friend virus erythroleukemic cells in vitro by serum from mice with dormant erythroleukemia

  1977cited by this paper
• Effect of interferon on growth and division cycle of Friend erythroleukemic murine cells in vitro

  1977cited by this paper
• Mediation of macrophage cytolytic and phagocytic activities by antibodies of different classes and class-specific Fc-receptors.

  1977cited by this paper
• Transmembrane interactions and the mechanism of capping of surface receptors by their specific ligands.

  1977cited by this paper
• Transmembrane control and surface modulation in animal cells.

  1977cited by this paper
• Characterization of the immune response to the major glycoprotein (gp71) of Friend leukemia virus. II. Response in C57BL/6 mice.

  1976cited by this paper
• Antiviral antibodies inhibit the lysis of tumour cells by anti-H–2 sera

  1976cited by this paper
• Characterization of the immune response to the major glycoprotein (gp 71) of Friend leukemia virus. I. Response in BALB/c mice.

  1976cited by this paper
• Fate of antibodies bound to lymphocyte surface. II.--Degradation and release of immune complexes.

  1976cited by this paper
• Nuclear chromatin changes during erythroid differentiation of friend virus induced leukemic cells.

  1976cited by this paper
• Killer cells: a functional comparison between natural, immune T-cell and antibody-dependent in vitro systems

  1976cited by this paper
• Independent control of the expression of several membrane-associated antigens of murine leukemia cells: metabolism and response to specific antiserum.

  1976cited by this paper
• Lymphocyte stimulation: a rapid multiparameter analysis.

  1976cited by this paper
• Properties of mouse leukemia viruses. XIII. Serum therapy of virus-induced murine leukemias.

  1976cited by this paper
• Inhibition of normal mouse lymphocyte mitogen responses by xenogeneic or allogeneic antibodies to the MuLV glycoprotein gp71.

  1976cited by this paper
• Polypeptides of mammalian oncornaviruses. II. Characterization of a murine leukemia virus polypeptide (p15) bearing interspecies reactivity.

  1975cited by this paper
• Functional interactions of viral and histocompatibility antigens at tumor cell surfaces.

  1975cited by this paper
• Polypeptides of mammalian oncornaviruses. II Characterization of murine leukemia virus polypeptide (p 15) bearing interspecies reactivity.

  1975cited by this paper
• Maintenance of latent herpetic infection: an apparent role for anti-viral IgG.

  1974cited by this paper
• Properties of mouse leukemia viruses. VIII. The major viral glycoprotein of Friend leukemia virus. Seroimmunological, interfering and hemagglutinating capacities.

  1974cited by this paper
• Antibody-induced redistribution of normal and tumor associated surface antigens.

  1974cited by this paper
• A proposed nomenclature for the virion proteins of oncogenic RNA viruses.

  1974cited by this paper
• Structural proteins of oncogenic ribonucleic acid viruses. Interspec II, a new interspecies antigen.

  1973cited by this paper
• Analysis of surface antigens on simian virus 40-transformed cells. II. Exposure of simian virus 40-induced antigens on transformed rabbit kidney and inbred hamster kidney cells by phospholipase C.

  1973cited by this paper
• Polypeptides of mammalian oncornaviruses. I. Isolation and serological analysis polypeptides from murine and feline C-type viruses.

  1973cited by this paper
• Analysis of surface antigens on simian virus 40-transformed cells. I. Unique antigenicity of simian virus 40-transformed outbred hamster kidney cell lines.

  1973cited by this paper
• Antibody‐induced changes in expression of an immunoglobulin surface antigen

  1973cited by this paper
• Hemoglobin biosynthesis in murine virus-induced leukemic cells in vitro: structure and amounts of globin chains produced.

  1972cited by this paper
• Endocytosis by lymphocytes of complexes of anti-Ig with membrane-bound Ig.

  1972cited by this paper
• IMMUNOGLOBULIN AND OTHER SURFACE ANTIGENS OF CELLS OF THE IMMUNE SYSTEM

  1971cited by this paper
• Rapid Cell Culture Assay Technique for Murine Leukaemia Viruses

  1971cited by this paper
• Products of RNA polymerases in HeLa cell nuclei.

  1971cited by this paper
• Effects of antibodies on L5178Y mouse leukemia cells cultured in vitro.

  1970cited by this paper
• ANTIGENIC MODULATION

  1968cited by this paper
• Erythrocytic maturation in vitro of murine (Friend) virus-induced leukemic cells.

  1966cited by this paper

• IMMUNOTHERAPY OF MURINE LEUKEMIA. XI. DIFFERENTIAL MICE TO THE IN VZTRO IMMUNOSUPPRESSIVE SUSCEPTIBILITY OF SPLEEN CELLS FROM SERUM-PROTECTED EFFECTS OF FRIEND LEUKEMIA VIRUS-INFECTED SPLENOCYTES

  2006cites this paper
• Role of Antibodies in Controlling Viral Disease: Lessons from Experiments of Nature and Gene Knockouts

  2000cites this paper
• Localization of a Passively Transferred Human Recombinant Monoclonal Antibody to Herpes Simplex Virus Glycoprotein D to Infected Nerve Fibers and Sensory Neurons In Vivo

  1999cites this paper
• Immunotherapy of murine leukemia. XI. Differential susceptibility of spleen cells from serum‐protected mice to the in vitro immunosuppressive effects of friend leukemia virus‐infected splenocytes

  1984cites this paper